Chris joined the Francis Crick Institute in 2023 as a Business Officer and now serves as Commercial and Translation Portfolio Analyst.
He holds a BSc in Medical Sciences with first-class honours from the University of Leeds and an MSc in Genomic Medicine with distinction from Imperial College London. During his MSc, Chris undertook a dissertation project at AstraZeneca as a Data Science Intern, investigating non-coding genetic variants associated with telomere biology disorders.
He has also completed an MBA Essentials programme at the London School of Economics with a 94% average, focusing on commercial strategy, organisational behaviour, and financial accounting.
